Search
21/10/2023
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
Socié G., Barba P., Barlev A., Sanz J., García-Cadenas I., Chevallier P., Fagioli F., Guzman-Becerra N., Kumar D., Ljungman P., Pigneux A., Sadetsky N., Yáñez San Segundo L., Shadman M., Storek J., Thirumalai D., Xing B., Mohty M.. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. BONE MARROW TRANSPLANTATION. 2023; 59(1)DOI:10.1038/s41409-023-02127-9. PMID:37865719. IF:4.500(Q1/2D).
20/10/2023
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Meca-Lallana J.E., Prieto González J.M., Caminero Rodríguez A.B., Olascoaga Urtaza J., Alonso A.M., Durán Ferreras E., Espinosa R., Dotor J., Romera M., Ares Luque A., Pérez Ruiz D., Calles C., Hernández M.A., Hervás García M., Mendoza Rodríguez A., Berdei Montero Y., Téllez N., Herrera Varó N., Sotoca J., Presas-Rodríguez S., Querol Gutierrez L.A., Hervás Pujol M., Batlle Nadal J., Martín Ozaeta G., Gubieras Lillo L., Martínez Yélamos S., Ramió-Torrentà L., Mallada Frechin J., Belenguer Benavides A., Gascón-Giménez F., Casanova B., Landete Pascual L., Berenguer L., Navarro L., Gómez Gutierrez M., Durán C., Rodríguez Regal A., Álvarez E., García-Estévez D.A., López Real A.M., Llaneza González M.A., Marzo Sola M.E., Sánchez-Menoyo J.L., Oterino A., Villaverde González R., Castillo-Triviño T., Álvarez de Arcaya A., Llarena C.. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and Therapy. 2023; 12(6)DOI:10.1007/s40120-023-00557-7. PMID:37861931. IF:4.000(Q1/2D).
20/10/2023
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
Ahn, MJ, Cho, BC, Felip, E, Korantzis, I, Ohashi, K, Majem, M, Juan-Vidal, O, Handzhiev, S, Izumi, H, Lee, JS, Dziadziuszko, R, Wolf, J, Blackhall, F, Reck, M, Alvarez, JB, Hummel, HD, Dingemans, AMC, Sands, J, Akamatsu, H, Owonikoko, TK, Ramalingam, SS, Borghaei, H, Johnson, ML, Huang, S, Mukherjee, S, Minocha, M, Jiang, TY, Martinez, P, Anderson, ES, Paz-Ares, L. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(22)DOI:10.1056/NEJMoa2307980. PMID:37861218. IF:96.300(Q1/1D).
20/10/2023
Spatial distribution and temporal dynamics of invasive and native mosquitoes in a large Mediterranean city
Ferraguti, M, Puente, JMD, Brugueras, S, Millet, JP, Rius, C, Valsecchi, A, Figuerola, J, Montalvo, T. Spatial distribution and temporal dynamics of invasive and native mosquitoes in a large Mediterranean city. The Science of the total environment. 2023; 896DOI:10.1016/j.scitotenv.2023.165322. PMID:37414178. IF:8.200(Q1/1D).
19/10/2023
If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression
Vicent-Gil, M, Trujols, J, Serra-Blasco, M, Navarra-Ventura, G, Puigdemont, D, Alemany, C, Crivillés, S, de Diego-Adeliño, J, Cardoner, N, Portella, MJ. If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression. EUROPEAN PSYCHIATRY. 2023; 66(1)DOI:10.1192/j.eurpsy.2023.2454. PMID:37855104. IF:7.200(Q1/1D).
18/10/2023
Where there is smoke there is risk: is there an irreversible threshold?
Garcia-Moll, X. Where there is smoke there is risk: is there an irreversible threshold?. EUROPEAN HEART JOURNAL. 2023; 44(42)DOI:10.1093/eurheartj/ehad685. PMID:37850511. IF:38.100(Q1/1D).